The Scan

The SARS-CoV-2 variant uncovered in California may be more transmissible and partially evade vaccine-induced antibody response, the Los Angeles Times reports.

In PNAS this week: immunotherapy for hard-to-treat breast cancers, effects of oncogenic histone H3K36M mutations, and more.

The Canadian COVID-19 Genomics Network aims to increase its genomic surveillance of emerging SARS-CoV-2 strains, the Canadian Press reports.

In PLOS this week: actionable pharmacogenetic variants in Hong Kong population, role of defective viral genomes, and more.

According to BBC News, the UK is to launch its new "high-risk" science agency.

In Science this week: cell-free DNA from urine explored to help diagnoses, more.

The Chronicle of Higher Education reports that the number of international graduate students in the US has fallen during the COVID-19 pandemic.

In Nature this week: analysis of SARS-CoV-2 genomes uncovered substrains in the US.

The UK has given the go-ahead to a SARS-CoV-2 human challenge trial, Reuters reports.

In Nucleic Acids Research this week: targeted splice sequencing study of myotonic dystrophy, structural variant genotyping tool, and more.

The Wall Street Journal reports that a sizable portion of the 150 million rapid antigen tests the US bought have gone unused.

In PNAS this week: single-cell whole-genome amplification approach for SNV detection, immune features linked to bone regeneration, and more.